drugset / Trial / NCT06190132
The Effect of Omega-3 Fatty Acids Versus Gabapentin in Uremic Pruritus in Hemodialysis Patients
RandomizedCrossoverSingle-blindTreatment
Summary
omega-3 fatty acids versus gabapentin in uremic pruritus in hemodialysis patients.
Timeline
- Start
- 2023-04-01
- Primary completion
- 2023-07-15
- Completion
- 2023-07-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Gabapentin | Small molecule | 100 mg | — |
| Comparator | Lovaza | Other / unclassified | 1 g | — |
Indications
No indication recorded.